| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.534 | 46.434 | 44.174 | 45.919 | - | 80.580 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 33.534 | 46.434 | 44.174 | 45.919 | - | 85.544 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 26.027 | 7.912 | 38.783 | 19.523 | - | -26.947 | 1.256 | 152 | 0 | 159.032 |
| Gross Profit/Loss - EUR | 7.506 | 38.522 | 5.391 | 26.396 | - | 112.491 | -1.256 | -152 | 0 | -159.032 |
| Net Profit/Loss - EUR | 6.500 | 37.593 | 4.949 | 26.074 | - | 111.645 | -1.256 | -152 | 0 | -159.032 |
| Employees | 0 | 1 | 1 | 2 | - | 4 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Mega Zoo Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 223 | 221 | 217 | 213 | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.211 | 66.422 | 103.146 | 162.317 | - | 193.329 | 182.858 | 183.197 | 182.641 | 22.589 |
| Inventories | 10.078 | 37.841 | 33.727 | 27.990 | - | 160.633 | 160.068 | 160.412 | 159.926 | 0 |
| Receivables | 25 | 27.928 | 68.203 | 115.265 | - | 26.223 | 22.711 | 22.782 | 22.713 | 22.586 |
| Cash | 2.108 | 653 | 1.216 | 19.062 | - | 6.474 | 79 | 3 | 3 | 3 |
| Shareholders Funds | 6.538 | 44.065 | 48.268 | 55.702 | - | 184.321 | 178.978 | 179.382 | 178.838 | 18.806 |
| Social Capital | 45 | 45 | 44 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Debts | 5.896 | 22.578 | 55.094 | 107.151 | - | 9.008 | 3.880 | 3.815 | 3.803 | 3.782 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Mega Zoo Pharma Srl